NASDAQ Gain Investor Support (KERX, GEVO, SPWR, ZIOP, CIMT)

New York, NY -- (SBWIRE) -- 02/12/2013 -- Keryx Biopharmaceuticals (NASDAQ:KERX) Keryx BioPharmaceuticals surged this morning, trading at an intraday of $7.23 (+9.21%) with over 6.2 million shares that have exchanged hands, will KERX continue to push towards the end of day? Stick around.

Gevo, Inc. (NASDAQ:GEVO) Gevo Inc. surged to the current high of day of $2.68 this morning and sold off, trading at an intraday of $2.5599 (+5.35%) with over 1.6 million shares exchanged, will GEVO continue to push towards the end of day? Stick around.

SunPower Corporation (NASDAQ:SPWR) Sunpower Corp. is following recent bullish momentum, trading at an intraday of $9.94 (+5.3%) with over 3.8 million shares traded, will SPWR continue to push towards the end of day? Stick around.

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) Phase 3 Trial of ZIOPHARM'S Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Events. Trading at an intraday of $4.69 (+17.54%) with over 3.5 million shares that have exchanged hands, will ZIOP continue to push towards the end of day? Stick around.

Cimatron Ltd. (NASDAQ:CIMT) The Board of Directors has approved a cash distribution of NIS 1.54 (approximately US$0.42) per share on outstanding ordinary shares, representing a total distribution of approximately $3.9 million. The distribution is payable on March 5th, 2013 to shareholders of record date of February 15th, 2013. The Company will release its fourth quarter financial results on February 19th, 2013. Trading at an intraday of $11.62 (+6.41%) with over 540,000 shares exchanged, will CIMT continue to push? Stick around.

View Full NASDAQ Report: http://toonicestocks.com/news/2876-nasdaq-gain-investor-support-kerx-gevo-spwr-ziop-cimt

About TooNiceStocks.com
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestocks or like us on Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.

None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.